Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Orditura

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Cancer|November 20, 1997
Adult Wilms' tumor: a case reportM Orditura, F De Vita, G Catalano
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2005
Adjuvant chemotherapy of gastric cancer: which regimens?F De Vita, M Orditura, F Ciardiello, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|October 1, 1994
[Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion]M Orditura, F De Vita, F Ciaramella, et al.
Panminerva Medica|May 7, 1999
A pilot study of adjuvant chemotherapy with double modulation of 5-fluorouracil by methotrexate and leucovorin in gastric cancer patientsF De Vita, M Orditura, A Auriemma, et al.
International Journal of Molecular Medicine|December 16, 1998
Increased serum levels of tumor necrosis factor-alpha are correlated to soluble intercellular adhesion molecule-1 concentrations in non-small cell lung cancer patientsF De Vita, M Orditura, S Infusino, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 24, 1999
Serum concentrations of proinflammatory cytokines in advanced non small cell lung cancer patientsF De Vita, M Orditura, A Auriemma, et al.
Oncology Reports|April 18, 1998
Circulating levels of soluble intercellular adhesion molecule-1 in non-small cell lung cancer patientsF De Vita, S Infusino, A Auriemma, et al.
Clinical and Experimental Immunology|September 10, 2009
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapyE Martinelli, R De Palma, M Orditura, et al.
Cancer Treatment Reviews|December 7, 2010
Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic targetF De Vita, F Giuliani, N Silvestris, et al.
Oncology Reports|May 9, 1998
Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell lung cancerF De Vita, M Orditura, A Auriemma, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Cancer|November 20, 1997
Adult Wilms' tumor: a case reportM Orditura, F De Vita, G Catalano
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2005
Adjuvant chemotherapy of gastric cancer: which regimens?F De Vita, M Orditura, F Ciardiello, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|October 1, 1994
[Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion]M Orditura, F De Vita, F Ciaramella, et al.
Panminerva Medica|May 7, 1999
A pilot study of adjuvant chemotherapy with double modulation of 5-fluorouracil by methotrexate and leucovorin in gastric cancer patientsF De Vita, M Orditura, A Auriemma, et al.
International Journal of Molecular Medicine|December 16, 1998
Increased serum levels of tumor necrosis factor-alpha are correlated to soluble intercellular adhesion molecule-1 concentrations in non-small cell lung cancer patientsF De Vita, M Orditura, S Infusino, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 24, 1999
Serum concentrations of proinflammatory cytokines in advanced non small cell lung cancer patientsF De Vita, M Orditura, A Auriemma, et al.
Oncology Reports|April 18, 1998
Circulating levels of soluble intercellular adhesion molecule-1 in non-small cell lung cancer patientsF De Vita, S Infusino, A Auriemma, et al.
Clinical and Experimental Immunology|September 10, 2009
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapyE Martinelli, R De Palma, M Orditura, et al.
Cancer Treatment Reviews|December 7, 2010
Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic targetF De Vita, F Giuliani, N Silvestris, et al.
Oncology Reports|May 9, 1998
Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell lung cancerF De Vita, M Orditura, A Auriemma, et al.
Pageof 6